Adalimumab (Humira)


Indications

XXXX


Pharmacology

Adalimumab Binds to Circulating and Membrane-Bound TNFα (see Anti-Tumor Necrosis Factor-α Therapy)

Metabolism


Administration

Dosage

Dose Adjustment

Use in Pregnancy (see Pregnancy)

Use During Breast Feeding


General Adverse Effects of Anti-Tumor Necrosis Factor-α (Anti-TNFα) Therapy (see Anti-Tumor Necrosis Factor-α Therapy)

Dermatologic Adverse Effects

Infectious Adverse Effects

Pulmonary Adverse Effects

Renal Adverse Effetcs

Rheumatologic Adverse Effects


References